DENPOZIN-SM
Description_Effects
DENPOZIN-SM is a combination medicine used for the effective management of type 2 diabetes mellitus. This condition occurs when the body becomes resistant to insulin or does not produce enough insulin, leading to elevated blood sugar levels. DENPOZIN-SM helps control these levels through a multi-action approach that targets different aspects of glucose regulation in the body. It contains three key components: Metformin, Sitagliptin, and Dapagliflozin. Metformin works by decreasing the amount of glucose produced by the liver, reducing the absorption of glucose from food, and improving the body’s sensitivity to insulin. Sitagliptin enhances the levels of incretin hormones, which increase insulin release and decrease sugar production in the liver when blood sugar levels are high. Dapagliflozin lowers blood glucose by helping the kidneys remove excess sugar through urine, thereby reducing overall sugar levels in the bloodstream. Together, these actions provide comprehensive control of blood sugar throughout the day, including after meals and during fasting. DENPOZIN-SM is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and routine blood sugar monitoring. Consistent use of this medication can significantly reduce the risk of diabetes-related complications and support long-term health in people with type 2 diabetes.
